Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Protein aggregation and the formation of highly insoluble amyloid structures is associated with a range of debilitating human conditions, which include Alzheimer's disease, Parkinson's disease, and the Creutzfeldt–Jakob disease. Muscle acylphosphatase (AcP) has already provided significant insights into mutational changes that modulate amyloid formation. In the present paper, we have used this system to investigate the effects of mutations that modify the charge state of a protein without affecting significantly the hydrophobicity or secondary structural propensities of the polypeptide chain. A highly significant inverse correlation was found to exist between the rates of aggregation of the protein variants under denaturing conditions and their overall net charge. This result indicates that aggregation is generally favored by mutations that bring the net charge of the protein closer to neutrality. In light of this finding, we have analyzed natural mutations associated with familial forms of amyloid diseases that involve alteration of the net charge of the proteins or protein fragments associated with the diseases. Sixteen mutations have been identified for which the mechanism of action that causes the pathological condition is not yet known or fully understood. Remarkably, 14 of these 16 mutations cause the net charge of the corresponding peptide or protein that converts into amyloid deposits to be reduced. This result suggests that charge has been a key parameter in molecular evolution to ensure the avoidance of protein aggregation and identifies reduction of the net charge as an important determinant in at least some forms of protein deposition diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M., & Stefani, M. (2002) · Nature · doi:10.1038/416507a · Cited by 2,434
Self-citationWhy are ?natively unfolded? proteins unstructured under physiologic conditions?
Uversky, V. N., Gillespie, J. R., & Fink, A. L. (2000) · Proteins: Structure, Function, and Genetics · doi:10.1002/1097-0134(20001115)41:3<415::aid-prot130>3.0.co;2-7 · Cited by 2,078
Protein misfolding, evolution and disease
Dobson, C. M. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01445-0 · Cited by 1,952
Self-citationSantoro, M. M., & Bolen, D. W. (1988) · Biochemistry · doi:10.1021/bi00421a014 · Cited by 1,582
Conway, K. A., Lee, S.-J., Rochet, J.-C., Ding, T. T., Williamson, R. E., & Lansbury, P. T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.571 · Cited by 1,541
Mutation of the Alzheimer's Disease Amyloid Gene in Hereditary Cerebral Hemorrhage, Dutch Type
Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I., van Duinen, S. G., Bots, G. T. A. M., Luyendijk, W., & Frangione, B. (1990) · Science · doi:10.1126/science.2111584 · Cited by 1,381
The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation
Nilsberth, C., Westlind-Danielsson, A., Eckman, C. B., Condron, M. M., Axelman, K., Forsell, C., Stenh, C., Luthman, J., Teplow, D. B., Younkin, S. G., et al. (2001) · Nature Neuroscience · doi:10.1038/nn0901-887 · Cited by 1,209
Nielsen, L., Khurana, R., Coats, A., Frokjaer, S., Brange, J., Vyas, S., Uversky, V. N., & Fink, A. L. (2001) · Biochemistry · doi:10.1021/bi002555c · Cited by 1,175
Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis
Booth, D. R., Sunde, M., Bellotti, V., Robinson, C. V., Hutchinson, W. L., Fraser, P. E., Hawkins, P. N., Dobson, C. M., Radford, S. E., Blake, C. C. F., et al. (1997) · Nature · doi:10.1038/385787a0 · Cited by 1,048
Self-citationDesigning conditions for in vitro formation of amyloid protofilaments and fibrils
Chiti, F., Webster, P., Taddei, N., Clark, A., Stefani, M., Ramponi, G., & Dobson, C. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3590 · Cited by 1,039
Self-citationMutation-Specific Functional Impairments in Distinct Tau Isoforms of Hereditary FTDP-17
Hong, M. (1998) · Science · doi:10.1126/science.282.5395.1914 · Cited by 1,003
Wischik, C. M., Novak, M., Thøgersen, H. C., Edwards, P. C., Runswick, M. J., Jakes, R., Walker, J. E., Milstein, C., Roth, M., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4506 · Cited by 939
Amyloid fibrils from muscle myoglobin
Fändrich, M., Fletcher, M. A., & Dobson, C. M. (2001) · Nature · doi:10.1038/35065514 · Cited by 799
Self-citationThe Structure of Amyloid Fibrils by Electron Microscopy and X-Ray Diffraction
SUNDE, M., & BLAKE, C. (1997) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60320-4 · Cited by 767
Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology
LIN, H., BHATIA, R., & LAL, R. (2001) · The FASEB Journal · doi:10.1096/fj.01-0377com · Cited by 644
Alternative conformations of amyloidogenic proteins govern their behavior
Kelly, J. W. (1996) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(96)80089-3 · Cited by 593
Lai, Z., Colón, W., & Kelly, J. W. (1996) · Biochemistry · doi:10.1021/bi952501g · Cited by 574
Acid-induced folding of proteins.
Goto, Y., Calciano, L. J., & Fink, A. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.2.573 · Cited by 568
Grabowski, T. J., Cho, H. S., Vonsattel, J. P. G., Rebeck, G. W., & Greenberg, S. M. (2001) · Annals of Neurology · doi:10.1002/ana.1009 · Cited by 523
Volles, M. J., & Lansbury, P. T. (2002) · Biochemistry · doi:10.1021/bi0121353 · Cited by 487
Lacroix, E., Viguera, A. R., & Serrano, L. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2145 · Cited by 439
Rizzu, P., Van Swieten, J. C., Joosse, M., Hasegawa, M., Stevens, M., Tibben, A., Niermeijer, M. F., Hillebrand, M., Ravid, R., Oostra, B. A., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302256 · Cited by 427
Kinetic partitioning of protein folding and aggregation
Chiti, F., Taddei, N., Baroni, F., Capanni, C., Stefani, M., Ramponi, G., & Dobson, C. M. (2002) · Nature Structural Biology · doi:10.1038/nsb752 · Cited by 422
Self-citationFarzan, M., Schnitzler, C. E., Vasilieva, N., Leung, D., & Choe, H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160115697 · Cited by 357
Barghorn, S., Zheng-Fischhöfer, Q., Ackmann, M., Biernat, J., von Bergen, M., Mandelkow, E.-M., & Mandelkow, E. (2000) · Biochemistry · doi:10.1021/bi000850r · Cited by 351
A role for destabilizing amino acid replacements in light-chain amyloidosis.
Hurle, M. R., Helms, L. R., Li, L., Chan, W., & Wetzel, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5446 · Cited by 348
Deposition of Transthyretin in Early Stages of Familial Amyloidotic Polyneuropathy
Mendes Sousa, M., Cardoso, I., Fernandes, R., Guimarães, A., & Saraiva, M. J. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63050-7 · Cited by 344
Liemann, S., & Glockshuber, R. (1999) · Biochemistry · doi:10.1021/bi982714g · Cited by 316
Partially Unfolded States of β2-Microglobulin and Amyloid Formation in Vitro
McParland, V. J., Kad, N. M., Kalverda, A. P., Brown, A., Kirwin-Jones, P., Hunter, M. G., Sunde, M., & Radford, S. E. (2000) · Biochemistry · doi:10.1021/bi000276j · Cited by 309
Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region.
Kamino, K., Orr, H. T., Payami, H., Wijsman, E. M., Alonso, M. E., Pulst, S. M., Anderson, L., O'dahl, S., Nemens, E. J., & White, J. A. (1992) · PubMed Central · Cited by 302
Dobson, C. M., Chiti, F., Taddei, N., White, P. M., Bucciantini, M., Magherini, F., & Stefani, M. (1999) · Nature Structural Biology · doi:10.1038/14890 · Cited by 278
Self-citationEffects of frontotemporal dementia FTDP‐17 mutations on heparin‐induced assembly of tau filaments
Goedert, M., Jakes, R., & Crowther, R. A. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00508-6 · Cited by 260
Pathogenic Effects of D23N Iowa Mutant Amyloid β-Protein
Van Nostrand, W. E., Melchor, J. P., Cho, H. S., Greenberg, S. M., & Rebeck, G. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104135200 · Cited by 245
Ramírez-Alvarado, M., Merkel, J. S., & Regan, L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150091797 · Cited by 228
De Jonghe, C. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.16.1665 · Cited by 223
Hereditary renal amyloidosis associated with a mutant fibrinogen α–chain
Benson, M. D., Liepnieks, J., Uemichi, T., Wheeler, G., & Correa, R. (1993) · Nature Genetics · doi:10.1038/ng0393-252 · Cited by 219
Miravalle, L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003154200 · Cited by 217
Dependence on solution conditions of aggregation and amyloid formation by an SH3 domain
Zurdo, J., Guijarro, J. I., Jiménez, J. L., Saibil, H. R., & Dobson, C. M. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4858 · Cited by 214
Self-citationMurrell, J. R., Spillantini, M. G., Zolo, P., Guazzelli, M., Smith, M. J., Hasegawa, M., Redi, F., Crowther, R. A., Pietrini, P., Ghetti, B., et al. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199912000-00002 · Cited by 205
Street, A. G., & Mayo, S. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9074 · Cited by 202
Comparison of Lethal and Nonlethal Transthyretin Variants and Their Relationship to Amyloid Disease
McCutchen, S. L., Lai, Z., Miroy, G. J., Kelly, J. W., & Colon, W. (1995) · Biochemistry · doi:10.1021/bi00041a032 · Cited by 198
FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10
Hasegawa, M., Smith, M. J., Iijima, M., Tabira, T., & Goedert, M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(98)01696-2 · Cited by 184
Otzen, D. E., Kristensen, O., & Oliveberg, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160086297 · Cited by 177
A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy
Nichols, W. C., Gregg, R. E., Brewer, H. B., & Benson, M. D. (1990) · Genomics · doi:10.1016/0888-7543(90)90288-6 · Cited by 176
Delisle, M.-B., Murrell, J. R., Richardson, R., Trofatter, J. A., Rascol, O., Soulages, X., Mohr, M., Calvas, P., & Ghetti, B. (1999) · Acta Neuropathologica · doi:10.1007/s004010051052 · Cited by 171
Structure of tau protein and assembly into paired helical filaments
Friedhoff, P., von Bergen, M., Mandelkow, E.-M., & Mandelkow, E. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00038-7 · Cited by 165
Tau Gene Mutation K257T Causes a Tauopathy Similar to Pick's Disease
Rizzini, C., Goedert, M., Hodges, J. R., Smith, M. J., Jakes, R., Hills, R., Xuereb, J. H., Crowther, R. A., & Spillantini, M. G. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.11.990 · Cited by 159
Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis.
Soutar, A. K., Hawkins, P. N., Vigushin, D. M., Tennent, G. A., Booth, S. E., Hutton, T., Nguyen, O., Totty, N. F., Feest, T. G., & Hsuan, J. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7389 · Cited by 145
Baures, P. W., Oza, V. B., Peterson, S., & Kelly, J. W. (1999) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(99)00066-8 · Cited by 135
Pick's disease associated with the novel Tau gene mutation K369I
Neumann, M., Schulz‐Schaeffer, W., Crowther, R. A., Smith, M. J., Spillantini, M. G., Goedert, M., & Kretzschmar, H. A. (2001) · Annals of Neurology · doi:10.1002/ana.1223 · Cited by 133
Charge Alterations of E22 Enhance the Pathogenic Properties of the Amyloid β‐Protein
Melchor, J. P., McVoy, L., & Van Nostrand, W. E. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742209.x · Cited by 125
Amyloid fibril formation by a helical cytochrome
Pertinhez, T., Bouchard, M., Tomlinson, E. J., Wain, R., Ferguson, S. J., Dobson, C. M., & Smith, L. J. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02384-5 · Cited by 122
Self-citationObici, L. P., Bellotti, V., Mangione, P. P., Stoppini, M., Arbustini, E., Verga, L., Zorzoli, I., Anesi, E., Zanotti, G., Campana, C., et al. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65167-x · Cited by 113
[6] Protein engineering in analysis of protein folding pathways and stability
Matouschek, A. T., & Fersht, A. R. (1991) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(91)02008-w · Cited by 100
Konno, T. (2001) · Biochemistry · doi:10.1021/bi002156h · Cited by 84
Loss of a metal-binding site in gelsolin leads to familial amyloidosis–Finnish type
Kazmirski, S. L., Isaacson, R. L., An, C., Buckle, A. M., Johnson, C. M., Daggett, V., & Fersht, A. R. (2002) · Nature Structural Biology · doi:10.1038/nsb745 · Cited by 75
Hereditary nephropathic systemic amyloidosis caused by a novel variant apolipoprotein A-I
Persey, M. R., Booth, D. R., Booth, S. E., van Zyl-Smit, R., Adams, B. K., Fattaar, A. B., Tennent, G. A., Hawkins, P. N., & Pepys, M. B. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00770.x · Cited by 72
Oligomerization of β-amyloid of the Alzheimer’s and the Dutch-cerebral-haemorrhage types
SIAN, A. K., Frears, E. R., El‐Agnaf, O. M. A., PATEL, B. P., Manca, M. F., Siligardi, G., Hussain, R., & Austen, B. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3490299 · Cited by 65
GOEDERT, M., GHETTI, B., & SPILLANTINI, M. G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06907.x · Cited by 61
Familial nephropathic systemic amyloidosis caused by apolipoprotein Al variant Arg26
Vigushin, D. M., Gough, J., Allan, D. R., Alguacil, A., Penner, B., Pettigrew, N. M., Quinonez, G. E., Bernstein, K. N., Booth, S. E., Booth, D. R., et al. (1994) · QJM · doi:10.1093/oxfordjournals.qjmed.a068909 · Cited by 61
Cited by
Protein Misfolding, Functional Amyloid, and Human Disease
Chiti, F., & Dobson, C. M. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.123901 · Cited by 6,423
Self-citationMolecular Mechanisms of Amyloidosis
Merlini, G., & Bellotti, V. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023144 · Cited by 1,920
Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins
Fernandez-Escamilla, A.-M., Rousseau, F., Schymkowitz, J., & Serrano, L. (2004) · Nature Biotechnology · doi:10.1038/nbt1012 · Cited by 1,658
Stefani, M., & Dobson, C. M. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0464-5 · Cited by 1,651
Self-citationRationalization of the effects of mutations on peptide andprotein aggregation rates
Chiti, F., Stefani, M., Taddei, N., Ramponi, G., & Dobson, C. M. (2003) · Nature · doi:10.1038/nature01891 · Cited by 1,072
“Human muscle acylphosphatase (AcP) is highly amenable to such studies, as its aggregation behaviour is well defined and extremely reproducibl”
BackgroundSelf-citation
Metadata
- Authors
- Chiti, F., Calamai, M., Taddei, N., Stefani, M., Ramponi, G., & Dobson, C. M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2002-12-10
- Volume
- 99
- Issue
- suppl_4
- Pages
- 16419-16426
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2157842863
- Cited by
- 273
- References
- 65
- FWCI
- 5.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.